AT2G16250 encodes a 967-amino acid transmembrane protein with:
Domain architecture:
Phosphorylation sites identified through mass spectrometry:
| Residue Range | Modified Residues | Functional Context |
|---|---|---|
| 832-844 | Ser836, Thr841 | Kinase activation loop |
| 276-306 | Tyr285, Ser299 | Extracellular LRR-JM interface |
This receptor belongs to the ARM3 clade of RG-I recognition receptors, distinguished by larger extracellular domains (ECDs) compared to ARM1/ARM2 clades .
Key findings from recent studies:
Binds RG-I fragments with K<sub>D</sub> = 92.4 ± 18.7 nM (SPR analysis)
Requires intact RG-I backbone structure for binding (endo-RG-I hydrolase sensitivity)
Triggers MAPK cascade activation (phosphorylation of MPK3/6 within 5-15 mins)
At2g16250 knockout plants show:
| Application | Protocol Details | Key Findings |
|---|---|---|
| Western Blot | 1:1000 dilution, 4°C overnight | Detects 110 kDa band in WT but not arm3a mutants |
| Co-IP | Protein A/G magnetic beads | Co-purifies with BAK1 (BRI1-associated kinase 1) |
| IHC | 1:200, Alexa Fluor 488 secondary | Localizes to plasma membrane and endosomes |
The antibody has been critical in demonstrating ARM3a's role in:
RG-I-induced transcriptional reprogramming (303 DEGs shared with OGDP10-15 elicitor)
Phosphorylation-dependent signal amplification (Y285F mutant loses 78% activity)
Following the "five pillars" of antibody characterization :
Genetic validation: No signal in at2g16250 T-DNA mutants
Orthogonal confirmation: Co-localization with RG-AuNPs (r = 0.89 vs immunofluorescence)
Independent antibody correlation: 92% concordance with HA-tagged ARM3a lines
MS verification: Identified 8 unique peptides covering 41% sequence
**Application-specific testing: Works in IF, WB, IP but not ELISA